Adams Street Partners LLC Takes Position in Billiontoone, Inc. $BLLN

Adams Street Partners LLC purchased a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN) during the fourth quarter, Holdings Channel reports. The fund purchased 1,711,430 shares of the company’s stock, valued at approximately $140,063,000. Billiontoone accounts for approximately 53.1% of Adams Street Partners LLC’s investment portfolio, making the stock its largest holding.

A number of other hedge funds have also recently made changes to their positions in the company. Lord Abbett & CO. LLC acquired a new stake in shares of Billiontoone during the fourth quarter valued at about $3,790,000. Rossby Financial LCC acquired a new stake in shares of Billiontoone during the fourth quarter valued at about $25,000. New York State Common Retirement Fund bought a new position in shares of Billiontoone during the fourth quarter worth about $419,000. JPMorgan Chase & Co. bought a new position in shares of Billiontoone during the fourth quarter worth about $32,078,000. Finally, Capital International Investors bought a new position in shares of Billiontoone during the fourth quarter worth about $14,568,000.

Insider Activity

In other Billiontoone news, insider Shan Riku Sakakibara sold 8,000 shares of the business’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $98.22, for a total value of $785,760.00. Following the transaction, the insider owned 212,000 shares of the company’s stock, valued at approximately $20,822,640. The trade was a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the company’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total value of $1,063,173.54. Following the transaction, the insider directly owned 21,900 shares in the company, valued at $2,200,293. This represents a 32.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 60,750 shares of company stock worth $5,979,598 over the last quarter.

Billiontoone Trading Up 1.5%

Shares of BLLN stock opened at $101.12 on Friday. The company has a market cap of $4.65 billion and a P/E ratio of 183.85. The stock has a 50 day simple moving average of $88.03 and a two-hundred day simple moving average of $88.20. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $138.70.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The business had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. The company’s revenue for the quarter was up 83.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.39) earnings per share. Research analysts forecast that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on BLLN shares. BTIG Research lowered their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Wells Fargo & Company lowered their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research report on Thursday, March 5th. Guggenheim raised their price objective on Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Wall Street Zen upgraded Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Finally, JPMorgan Chase & Co. raised their price objective on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.